Diclofenac Sodium | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Diclofenac Sodium
Health Canada Patents

AMI Lifesciences is Driven by Chemistry. Powered by People.

Contact Supplier

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

Contact Supplier

Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

Contact Supplier

Quotient Sciences- Molecule to Cure. Fast.

Contact Supplier

pharmacompass-2-m-2025-08-25

Diclofenac Sodium

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

109 API Suppliers, 21 USDMF, 17 CEP/COS, 13 JDMF, 9 EU WC, 22 KDMF, 31 NDC API, 44 Listed Suppliers, $ API Reference Price

109 API Suppliers
21 USDMF
17 CEP/COS
13 JDMF
9 EU WC
22 KDMF
31 NDC API
44 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

47 Drugs in Development

47 Drugs in Development

FINISHED DOSAGE FORMULATIONS

503 FDF Dossiers, 100 FDA Orange Book, 100 Europe, 38 Canada, 62 South Africa, 203 Listed Dossiers

503 FDF Dossiers
100 FDA Orange Book
100 Europe
38 Canada
62 South Africa
203 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;TOPICAL - 2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, DELAYED RELEASE;ORAL - 50MG;0.2MG, TABLET, DELAYED RELEASE;ORAL - 75MG;0.2MG, SOLUTION;TOPICAL - 1.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL;TOPICAL - 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL;TOPICAL - 1%, SOLUTION;INTRAVENOUS - 37.5MG/ML (37.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SOLUTION;TOPICAL - 2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, DELAYED RELEASE;ORAL - 50MG;0.2MG
TABLET, DELAYED RELEASE;ORAL - 75MG;0.2MG
SOLUTION;TOPICAL - 1.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
GEL;TOPICAL - 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
GEL;TOPICAL - 1%
SOLUTION;INTRAVENOUS - 37.5MG/ML (37.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 7 Evonik, 1 Rochem International Inc, 11 SPI Pharma, 9 DKSH, 12 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 11 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 Capital Farma, 6 Kirsch Pharma, 1 ACG Worldwide, 15 Actylis, 3 Aeon Procare, 3 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 48 BASF, 1 BioSpectra, 1 CD Formulation, 18 Corel Pharma Chem, 7 DFE Pharma, 3 Doshion Polyscience, 1 Esteem Industries, 3 Finar, 12 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 13 Ideal Cures, 4 Ingredion Pharma Solutions, 24 Kerry, 3 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 2 Lubrizol Life Science Health, 16 Microlex e.U, 2 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 4 Pharmatrans-Sanaq, 7 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 24 Roquette, 15 Seppic, 2 Shandong Focus Biotechnology Co., Ltd, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 11 Sigachi Industries, 4 Silverline Chemicals, 2 The Dow Chemical Company, 3 Ulanqab Kema New Material, 2 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

69 Coating Systems & Additives, 66 Fillers, Diluents & Binders, 50 Solubilizers, 43 Direct Compression, 43 Thickeners and Stabilizers, 43 Controlled & Modified Release, 42 Topical, 40 Granulation, 39 Disintegrants & Superdisintegrants, 27 Parenteral, 23 Lubricants & Glidants, 23 Film Formers & Plasticizers, 19 Taste Masking, 19 Emulsifying Agents, 16 Co-Processed Excipients, 12 Chewable & Orodispersible Aids, 10 API Stability Enhancers, 9 Surfactant & Foaming Agents, 8 Rheology Modifiers, 5 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules

69 Coating Systems & Additives
66 Fillers, Diluents & Binders
50 Solubilizers
43 Direct Compression
43 Thickeners and Stabilizers
43 Controlled & Modified Release
42 Topical
40 Granulation
39 Disintegrants & Superdisintegrants
27 Parenteral
23 Lubricants & Glidants
23 Film Formers & Plasticizers
19 Taste Masking
19 Emulsifying Agents
16 Co-Processed Excipients
12 Chewable & Orodispersible Aids
10 API Stability Enhancers
9 Surfactant & Foaming Agents
8 Rheology Modifiers
5 Empty Capsules
5 Coloring Agents
4 Vegetarian Capsules

DIGITAL CONTENT

63 News #PharmaBuzz

63 News #PharmaBuzz

GLOBAL SALES INFORMATION

40 US Medicaid Prescriptions, 96 Regulatory FDF Prices

40 US Medicaid Prescriptions
96 Regulatory FDF Prices

MARKET PLACE

66 APIs, 23 FDF Dossiers

66 APIs
23 FDF Dossiers

PATENTS & EXCLUSIVITIES

26 US Patents, 1 Health Canada Patents

26 US Patents
1 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 1 Others

2 EDQM
1 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 25 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

1 All

01 1Pfizer Canada Inc.

filter Patent Reset all filters

1 All

01 12082944

filter Product Reset all filters

1 All

01 1Diclofenac Sodium | Misoprostol

filter Dosage Reset all filters

1 All

01 1Tablet

filter Exp Date Reset all filters

1 All

01 12011-05-01

Product Main Page

01

Pfizer Canada Inc.

Diclofenac Sodium, Misoprostol

Pharmaconex

Not Confirmed

Pfizer Canada Inc.

Pharmaconex

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2011-05-01

Date Granted : 1998-11-24

Diclofenac Sodium, Misoprostol

Brand Name : ARTHROTEC 75

Patent Number : 2082944

Filing Date : 1991-05-01

Strength per Unit : 75mg / 200mcg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2011-05-01

Date Granted : 1998-11-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!